AMEX

GMO Beyond China ETF (BCHI)

368 Thanks from members

The GMO Beyond China ETF (BCHI) demonstrates robust performance as of mid-2026, driven by global supply chain shifts and heavy allocations in major tech and financial holdings outside mainland China, significantly outperforming the Diversified Emerging Markets category.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →